SHAKITA JOHNSON: Open Payments
NPI 1720710791 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 10 payments from 7 companies in 2025. Trend: 2023 $97 · 2024 $0 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $278 |
| Neurocrine BioSciences, Inc. | 1 | $175 |
| Amgen Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $111 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Braeburn Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: CAPLYTA, INGREZZA, Epclusa, UZEDY, BRIXADI, COBENFY.
Industry payments across IL — which companies pay providers there.
